Navigation Links
Talyst Holds User Group Meeting & Two-Day Customer Education Workshop
Date:9/17/2012

KIRKLAND, Wash., Sept. 17, 2012 /PRNewswire/ -- Talyst, a market leader in pharmacy automation, announces User Group meeting and a two-day workshop at Central DuPage Hospital, a member of Cadence Health, in Winfield, Ill. from September 18–19.

The User Group meeting will give customers the opportunity to preview new and forth coming Talyst products & services and best practices. The meeting allows attendees to build a community of knowledge sharing and collaboration between Talyst customers. The four education workshops will help current customers maximize their Talyst technologies.

"Our User Groups are a great venue for our customers to network," said Carla Corkern, Chief Executive Officer at Talyst. "The meeting provides a place for our customers to share ideas and best practices with their Talyst technologies."

For more information on the workshop and User Group meeting, visit http://talyst.com/training/.

About Talyst
Talyst is a leader in pharmacy automation and engineers the safer pharmacy. Our solutions provide enterprise-wide medication management across your entire health system to offer greater inventory control, enhanced workflow efficiency, and improved patient safety. As of 2012, Talyst has installed automated systems in more than 600 integrated healthcare systems, acute-care hospitals, long-term care facilities, and correctional institutions. We offer a powerful software platform with a suite of hardware components to meet your specific needs. Follow us on Twitter @Talyst_Inc or visit us at www.talyst.com.


'/>"/>
SOURCE Talyst
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Sacred Heart Medical Center Deploys Talysts Pharmacy Automation for Inventory Control and Improved Patient Safety
2. Talyst Implements Over Four Hundred 340B Programs
3. Talyst Announces AutoSplit Contract Pharmacy at 340B Coalition
4. Talyst Announces New Automated Medication Packager
5. Federal Appeals Court Upholds Fraud Verdict Against Cornell University Medical School For Misuse Of NIH Aids Funding
6. Online Career Service Holds Third Virtual Job Summit
7. U.S. Court of Appeals Upholds Validity of Lillys Alimta Compound Patent
8. Sinovac Holds 2012 Annual General Meeting of Shareholders
9. Mike Golic, ESPN Radio Personality and Former Philadelphia Eagle, Holds Pre-Season "Training Camp" for People With Type 2 Diabetes
10. Judge Upholds $3.3 Million Judgment In Favor of Fox Insurance Company Against Former Pharmacy Benefit Manager
11. LDM Group and Polyglot Systems Partnership Brings Easy-to-Understand Medication Instructions to Over Twelve Languages
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... May 24, 2013 Solta Medical, Inc. (NASDAQ: ... market, today reported Dr. Edward W. Knowlton ... of Directors effective immediately.  Dr. Knowlton is the founder of ... as a director since 1996. "On behalf of ... team, I would like to thank Ed for his tireless ...
(Date:5/24/2013)... 24, 2013  Auxilium Pharmaceuticals, Inc. (Nasdaq: ... in the Deutsche Bank Health Care Conference to be ... Mr. Adrian Adams , Chief Executive ... of the Company and its product pipeline at 12:00 ... (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) The presentation ...
(Date:5/24/2013)... GARDEN CITY, England and ... Heptares Therapeutics, the leading GPCR drug discovery and development company, is ... Usui as a Consultant to augment the Company,s business ... territories. Mr Usui has more than 15 years of ... industry including senior roles at Perlegen Sciences, Inc., Roche Pharma ( ...
Breaking Medicine Technology:Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc. 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2
... (NASDAQ: CYBX ), a global leader in epilepsy ... year ended April 29, 2011.   Annual ... the fifty-three week fiscal 2010, without adjustment for the extra ... $190.5 million, a 14% increase from $167.8 million; U.S. ...
... China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED ), ... financial results for the fourth fiscal quarter ("4Q FY2010") and the ... FY20 10 Highlight sFor   ... EndedMarch   31,   2010March ...
Cached Medicine Technology:Cyberonics Reports Record Fiscal 2011 Results and Provides Fiscal 2012 Guidance 2Cyberonics Reports Record Fiscal 2011 Results and Provides Fiscal 2012 Guidance 3Cyberonics Reports Record Fiscal 2011 Results and Provides Fiscal 2012 Guidance 4Cyberonics Reports Record Fiscal 2011 Results and Provides Fiscal 2012 Guidance 5Cyberonics Reports Record Fiscal 2011 Results and Provides Fiscal 2012 Guidance 6Cyberonics Reports Record Fiscal 2011 Results and Provides Fiscal 2012 Guidance 7Cyberonics Reports Record Fiscal 2011 Results and Provides Fiscal 2012 Guidance 8China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 2China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 3China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 4China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 5China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 6China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 7China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 8China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 9China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 10China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 11China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 12China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 13China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 14China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 15China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 16China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 17China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 18China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 19China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 20China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 21China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 22China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 23China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 24China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 25
(Date:5/25/2013)... IBISWorld estimates that revenue for the Cell Therapy ... 28.7% to $1.0 billion in the five years to 2013, ... no new cell therapy products were introduced, according to IBISWorld ... period. In the years since, however, the Food and Drug ... to the industry's fast growth during the five years to ...
(Date:5/25/2013)... For college students, few events can ... are turning to prescription stimulants like Adderall to ... on this, go to http://www.sciencedaily.com/releases/2013/05/130501145151.htm . , ... students who pick up Adderall, “just to help ... a physical and psychological dependency. While initially they ...
(Date:5/25/2013)... 25, 2013 Ayurveda is the ... "knowledge or wisdom of life". While a medical science, its ... transformation of consciousness. Its fundamental philosophy is that disease is ... environment. It believes that in order to re-establish optimal health, ... and then adopt a life style which brings us back ...
(Date:5/25/2013)... The current residents of Back2Basics - Long Term Drug ... all came together Saturday, May 18th to celebrate the company's ... the residents got up to thank Roy Duprez, CEO and ... to recovery, and giving them a second chance at life. ... after realizing the need for a long-term facility. What ...
(Date:5/25/2013)... May 25, 2013 http://www.resource4thepeople.com/defectivedrugs/Actos-Bladder-Cancer-Lawsuit.html ... a judge's overturning of a jury's award of $6.5 ... first trial* in the country over allegations that the ... court files. , The judge in the case ruled ... show his cancer was caused by the medication.** , ...
Breaking Medicine News(10 mins):Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals 2Health News:Ayurveda Education Programs Offered by the California College of Ayurveda Include Panchakarma Certification, Practitioner Courses, and Body Therapy Classes 2Health News:Back2Basics Drug and Alcohol Rehabilitation Center Celebrates Their 3rd Anniversary 2Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 2Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 3Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 4
... Women who exercise by doing household chores like dusting, ... cancer, suggests a new study.// ,The research ... from nine European countries and found that doing housework ... the online edition of BBC News. , ,It ...
... 2002 Gay Pride, San Francisco Department of Public Health launched ... ,In the above said campaign, a cartoon penis by name ... of homo whores who had gathered there to get themselves ... not happy with the Ad and scoffed at the cartoon ...
... Medical Association (IMA) will oppose the government's plan to ... IMA will oppose the move to administer injections instead ... president Sanjeev Malik told IANS here. ,Malik ... that began Wednesday and to hand over charge to ...
... now strawberry wine will add variety from Himachal Pradesh.// ... Marketing Corp's (HPMC) juice and wine processing plant in Mandi ... was produced after year-long research by experts and will be ... Kinnaur district, which produces some of the best wines in ...
... disorder, characterized by inflammation of synovial tissue leading //to ... joints. Investigations made on laboratory rats prove that women ... ,Researchers at the Mayo Clinic have produced a new ... human RA patients and increased incidence of the disease ...
... you know that a flabby waist certainly points to a greater ... ,A recent study has revealed that the risk for coronary illness ... figure one sports a podgy flabby waistline. ,The diameter along the ... This roughly amounts to an imaginary line cutting through the body ...
Cached Medicine News:Health News:Rheumatoid Arthritis and Sex Bias 2
Frequency 55 Toric XR is a great option for those with high levels of astigmatism...
... SofLens66 Toric lens are fit ... current soft toric lens wearers who ... with the health and convenience of ... want the convenience of contact lenses; ...
The Heine C series binocular loupes offer extremely low weight (46g), crisp views, and quality German construction in an affordable instrument....
C 2.3K with lightweight headband: the practical alternative for spectacle-wearers. Delivered in protective designer case....
Medicine Products: